You are here
URO ONCO is an important source of education and scientific information for many healthcare professionals in uro-oncology. This platform is an initiative from the European Association of Urology, in cooperation with European Urology and Elsevier. It is funded by unrestricted educational grants from pharmaceutical and medical device or equipment companies.
The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology, immunology, neuroscience, infectious disease, and cardiovascular and metabolic diseases.
Driven by our commitment to patients, Janssen develops innovative products, services and healthcare solutions to help people throughout the world.
More information can be found at www.janssen-emea.com.
EAU 2017 Scientific Programme and Sessions
View the Scientific Programme and Sessions of the 2017 EAU Annual Congress, Munich, Germany.